In today’s Pharma Pulse, Augmentin XR is the first drug approved under the FDA's new CNPV pilot program and much more.
The 20th installment of Trade & Channel Strategies carried on with a focus on boosting access to medication.
Hear how “delivery intelligence” is transforming the last mile of pharmaceutical logistics from Jay McHarg, CEO of AeroSafe Global.
In today’s Pharma Pulse, the University of Maryland expands its medical class to combat physician shortages and much more.
Having said that, Roth centered this morning’s keynote on “Navigating Disruption in the Pharmaceutical Channels,” a ...
In today’s Pharma Pulse, new trials confirm AI chatbots are a successful and sustainable tool for increasing pneumococcal ...
The Health Data, Technology, and Interoperability (HTI-4) Final Rule aims to strengthen the nation’s health IT ecosystem by ...
The Health Data, Technology, and Interoperability (HTI-4) Final Rule aims to strengthen the nation’s health IT ecosystem by ...
This shift in data analysis enables what can be called a “precision medical affairs” approach. Instead of a one-size-fits-all ...
In the final part of his Pharma Commerce video interview, Ed Schoonveld, value and access advisor for Schoonveld Advisory and ...
In today’s Pharma Pulse, the ACIP votes to end the decades-long universal hepatitis B birth dose recommendation; meanwhile, ...
In today’s Pharma Pulse, Dr. Richard Pazdur retires from his CDER director role weeks after his appointment, and much more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback